Breast cancer treatment without tamoxifen drug - non prescription
Cognitive Bias: The Downside of Shared Decision Making | JCO Clinical Cancer Informatics
5 tips for scientific survival from the Father of Tamoxifen
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials - The Lancet
Tamoxifen Not Associated With Higher Risk for Cataracts in Women With DCIS - Oncology Nurse Advisor
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology
Why So Many of Us Quit Taking Tamoxifen | FORCE: Facing our Risk of Cancer Empowered Blog
Tamoxifen: what you should and shouldn't avoid - OWise UK
Gels | Free Full-Text | Tamoxifen Citrate Containing Topical Nanoemulgel Prepared by Ultrasonication Technique: Formulation Design and In Vitro Evaluation
mamo.cz - Tamoxifen class drugs reduce breast cancer rates by more than a third in women at high risk
Cancers | Free Full-Text | TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer
Tamoxifen and Breast Cancer (Yale Fastback Series): DeGregorio, Michael W., Wiebe, Valerie J.: 9780300079517: Amazon.com: Books
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial - The Lancet
Tamoxifen Accelerates Endothelial Healing by Targeting ERα in Smooth Muscle Cells | Circulation Research
.jpg "Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis")
Risk-Reducing Medications for Women at High-Risk of Breast Cancer: New Recommendations and Missed Opportunities | Public Health Sciences Division | Washington University in St. Louis
Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an Intervention Mapping framework | SpringerLink
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial - The Lancet
Why I'm taking tamoxifen to avoid breast cancer | MD Anderson Cancer Center
Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering | Scientific Reports
Medicina | Free Full-Text | Pharmacogenomics, CYP2D6, and Tamoxifen: A Survey of the Reasons Sustaining European Clinical Practice Paradigms
Making Choices
VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer | 2 Minute Medicine
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic | British Journal of Cancer
Tamoxifen to prevent breast cancer? - Website for Liz O'Riordan
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial | Journal of Clinical Oncology
